Mohamed Shabbeer Imtiaz Ahamed

Mr. Mohamed Shabbeer Imtiaz Ahamed

Faculty of Medicine, Tbilisi State Medical University, Tbilisi, Georgia
orcid
Always ready to learn and grow!

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 December 2025 in Clinical Hematology International
Verified
Journal Article
Open access
PDF file
SNSoumiya Nadar
Soumiya Nadar
TDTaha Kassim Dohadwala
Taha Kassim Dohadwala
NKNitish Kumaresan
Nitish Kumaresan
Mohamed Shabbeer Imtiaz AhamedMohamed Shabbeer Imtiaz Ahamed
Mohamed Shabbeer Imtiaz Ahamed
SFSumia Fatima
Sumia Fatima
Clonal Hematopoiesis of indeterminate potential (CHIP) has been increasingly recognised as a risk factor for cardiovascular disease (CVD). Recent epidemiological and experimental studies have linked CHIP as an independent risk factor for myocardial infarction, stroke, and coronary artery disease, with specific mutations carrying a higher CVD risk. During the aging process, somatic mutations in genes, including DNMT3A and TET2, accumulate in the hematopoietic stem cells (HSCs), conferring both epigenetic and metabolic advantages that not only drive hematopoiesis towards a pro-inflammatory myeloid lineage but also reprogram innate immune cells, promoting a persistent inflammatory state. These myeloid derivatives, via increased IL-1β and IL-6 production, establish a pro-atherogenic environment and contribute to plaque instability, leading to an increased thrombotic risk and accelerated vascular aging. Although routine screening is not recommended for asymptomatic adults, targeted detection in high-risk individuals could benefit from preventive strategies. Incorporating CHIP into risk models may enable precision prevention, but prospective trials are needed to determine whether CHIP-guided interventions improve cardiovascular outcomes.

5 November 2024 in International Journal of Science and Research (IJSR)
Verified
Journal Article
Closed access
VKVenkata Saya Kiran Kumar
Venkata Saya Kiran Kumar
NNNikhil Bharadwaja Nandivada
Nikhil Bharadwaja Nandivada
NRNandavinamani Shivanand Raghavendra
Nandavinamani Shivanand Raghavendra
VNVaishnavi Nandivada
Vaishnavi Nandivada
URUsama Ahmed Rizvi
Usama Ahmed Rizvi
AJAjin Mathews John
Ajin Mathews John
Objective: To highlight the noticeable thermal effects of laptops on not only dermal tissues and genitals but also

13 February 2025
Verified
Other
Closed access
Mohamed Shabbeer Imtiaz AhamedMohamed Shabbeer Imtiaz Ahamed
Mohamed Shabbeer Imtiaz Ahamed
ATAngel Sara Thangamuni
Angel Sara Thangamuni

3 April 2026 in Surgical Neurology International
Verified
Journal Article
Open access
DRDhvanit Rajdeep
Dhvanit Rajdeep
AAAhmed Saleh Ahmed Abdelkader
Ahmed Saleh Ahmed Abdelkader
HSHashim Mohamed Siraj
Hashim Mohamed Siraj
FIFarhad Islam
Farhad Islam
VSVedika Saxena
Vedika Saxena
SASyed Khaja Ayaanuddin
Syed Khaja Ayaanuddin
Background: Drug-resistant epilepsy (DRE), characterized by inadequate seizure control despite adequate trials of multiple antiepileptic medications, affects a substantial proportion of the global epilepsy population. Recent advances in neuromodulation techniques have demonstrated promise as adjunctive therapeutic approaches for managing treatment-resistant epilepsy. Transcranial magnetic stimulation (TMS) and vagus nerve stimulation (VNS) represent emerging interventions for patients who fail conventional pharmacological management. Methods: A comprehensive search was performed for multiple databases such as PubMed, Cochrane Library, and Google Scholar. Search was done for studies from 1995 to 2024, which will meet our inclusion criteria and exclusion criteria. We selected 36 studies that include randomized controlled trials, observational studies, and retrospective analyses. Our primary outcome is seizure recurrence, and the secondary outcomes are adverse events. Our systematic review is registered in PROSPERO, and its ID is CRD42025629381. Results: Approximately 47% of patients treated with either TMS or VNS were found to have a mean seizure reduction of over 50%, which also contributed to the results of our data interpretation. Even in several institutional studies, it was additionally found that more than 60% of patients showed significant improvements in seizure control. Conclusion: Evidence reported that both TMS and VNS greatly improve seizure control in patients with drug-resistant epilepsy, potentially enhancing quality of life and reducing seizure frequency. A large amount of our findings support the integration of neuromodulation techniques into future treatment regimens for drug-resistant epilepsy, which might be accompanied by calls for future clinical trials.

4 May 2026 in Asian Journal of Neurosurgery
Verified
Journal Article
Open access
DRDhvanit Rajdeep
Dhvanit Rajdeep
SKShreevikaa Kannan
Shreevikaa Kannan
RJRaafiyah F. A. Jan
Raafiyah F. A. Jan
SBSaniyah M. Baig
Saniyah M. Baig
NANandini Ahuja
Nandini Ahuja
Mohamed Shabbeer Imtiaz AhamedMohamed Shabbeer Imtiaz Ahamed
Mohamed Shabbeer Imtiaz Ahamed
Intracranial aneurysms carry a life-threatening risk of subarachnoid hemorrhage, and the comparative roles of microsurgical clipping and endovascular coiling continue to evolve alongside rapid technological advancement. This narrative review synthesizes contemporary evidence on microsurgical clipping for cerebral aneurysms, evaluating intraoperative adjunctive technologies, location-specific surgical strategies, clinical outcomes, and emerging future directions. A structured literature search was conducted across PubMed/MEDLINE, Scopus, and Google Scholar for peer-reviewed studies published between 2000 and 2025. Following systematic deduplication and eligibility screening, 55 studies were included in a thematic narrative synthesis. Microsurgical clipping achieves complete aneurysm occlusion in 95 to 99% of cases, with durable long-term results and low retreatment rates. Intraoperative adjuncts, particularly indocyanine green videoangiography and robotic-assisted platforms, have demonstrably reduced ischemic complications. Endovascular coiling offers comparable procedural safety for small-necked aneurysms and facilitates faster short-term recovery; however, recanalization affects a significant proportion of large or wide-necked lesions. Treatment selection is primarily determined by aneurysm morphology, anatomical location, patient comorbidities, and institutional expertise rather than rigid algorithmic criteria. Augmented reality navigation and artificial intelligence-assisted clip positioning represent the most promising emerging technologies for surgical precision and resident training. Microsurgical clipping remains the definitive treatment for intracranial aneurysms requiring long-term occlusion security. Optimal management must integrate individual aneurysm architecture and patient physiology rather than rely on a single-modality treatment algorithm.